Jobs

Currently 3953 jobs

Candidates Login

CV Database

Let the jobs come to you!

Company Login

Site Newsletter

Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

PharmiWeb on Facebook

Advertising

Press Releases

submit a press release

233 Press Releases

1 2 3 4 5 6 7 8

Date	Title	Company
25 Jan 11	Teva Receives FDA Action Letter For Generic Lovenox®	Teva Pharmaceutical Industries Ltd., Published by Business Wire
24 Jan 11	Teva Enters Into $1.5 Billion Syndicated Credit Facility	Teva Pharmaceutical Industries Ltd., Published by Business Wire
19 Jan 11	Teva Congratulates Professor Moussa Youdim, Winner of the 2010 EMET Prize for Brain Science	Teva Pharmaceutical Industries Ltd., Published by Business Wire
11 Jan 11	Teva Calls 1.75% Convertible Debentures Due 2026 for Redemption	Teva Pharmaceutical Industries Ltd., Published by Business Wire
11 Jan 11	Teva to Report Fourth Quarter and Full Year 2010 Financial Results on February 8, 2011	Teva Pharmaceutical Industries Ltd., Published by Business Wire
07 Jan 11	Teva to Present at the 29th Annual J.P. Morgan Healthcare Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
05 Jan 11	Teva Completes Acquisition of Théramex	Teva Pharmaceutical Industries Ltd., Published by Business Wire
04 Jan 11	Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
23 Dec 10	FDA Issues Complete Response Letter for Lower-Volume Glatiramer Acetate sNDA	Teva Pharmaceutical Industries Ltd., Published by Business Wire
22 Dec 10	Teva and Takeda Settle Generic ACTOS® and ACTOplus met® Litigation	Teva Pharmaceutical Industries Ltd., Published by Business Wire
11 Dec 10	Teva Files Citizen Petition Surrounding Purported Generic Version of COPAXONE®	Teva Pharmaceutical Industries Ltd., Published by Business Wire
09 Dec 10	Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis	Teva Pharmaceutical Industries Ltd., Published by Business Wire
06 Dec 10	Teva to Present at the NASDAQ OMX 25th Investor Program	Teva Pharmaceutical Industries Ltd., Published by Business Wire
03 Dec 10	Teva Comments on Patent Infringement Lawsuit Filed by Momenta and Sandoz	Teva Pharmaceutical Industries Ltd., Published by Business Wire
01 Dec 10	Teva Announces $1 Billion Share Repurchase Program	Teva Pharmaceutical Industries Ltd., Published by Business Wire
15 Nov 10	Teva Highlights QNAZE™ HFA Phase III Data at the 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology	Teva Pharmaceutical Industries Ltd., Published by Business Wire
10 Nov 10	Teva to Present at the Credit Suisse 2010 Healthcare Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
04 Nov 10	Teva Presents Respiratory Growth Strategy	Teva Pharmaceutical Industries Ltd., Published by Business Wire
02 Nov 10	Teva Reports Record Third Quarter 2010 Results	Teva Pharmaceutical Industries Ltd., Published by Business Wire
30 Oct 10	Teva Invites Public to Listen to Its Respiratory Opportunity Meeting Webcast	Teva Pharmaceutical Industries Ltd., Published by Business Wire
28 Oct 10	Teva to Acquire Théramex, Merck KGaA’s European Based Women’s Health Business	Teva Pharmaceutical Industries Ltd., Published by Business Wire
18 Oct 10	Teva Announces Launch of Generic Prevacid® SoluTab in the United States	Teva Pharmaceutical Industries Ltd., Published by Business Wire
16 Oct 10	Early Initiation of Treatment with Copaxone® Provides Greater Effects in Delaying Conversion to Clinically Definite MS	Teva Pharmaceutical Industries Ltd., Published by Business Wire
15 Oct 10	New Data Evaluating Laquinimod for the Treatment of Multiple Sclerosis Demonstrate Neuroprotective Effects	Teva Pharmaceutical Industries Ltd., Published by Business Wire
30 Sep 10	Teva Provides Update on Status of Neutroval™ (G-CSF) Biologics License Application Submitted to the U.S. Food and Drug Administration	Teva Pharmaceutical Industries Ltd., Published by Business Wire
22 Sep 10	Teva Files Complaint against Mylan for Infringement of Four Copaxone®-Related Patents	Teva Pharmaceutical Industries Ltd., Published by Business Wire
20 Sep 10	Oral Laquinimod Demonstrated Sustained Efficacy and Safety in Patients with Multiple Sclerosis	Teva Pharmaceutical Industries Ltd., Published by Business Wire
17 Sep 10	Teva to Present at the UBS Global Life Sciences Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
10 Sep 10	Teva to Present at the Morgan Stanley Global Healthcare Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
08 Sep 10	Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone® Litigation	Teva Pharmaceutical Industries Ltd., Published by Business Wire

1 2 3 4 5 6 7 8

subscribe in a reader

Advertising

Share | | |

Site Map
Privacy & Security
Cookies
Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.